Lääkemääräysten alkuperän määrittäminen terveydenhuollon käyntitietojen avulla. Menetelmäraportti Oulu-hankkeessa käytetystä algoritmista

Autor: Miettinen, J, Aaltonen, K, Martikainen, JE

Tutkimustietoa eri terveydenhuollon sektoreiden kokonais- ja päällekkäiskäytöstä on vähän saatavilla, mikä johtuu siitä, että eri sektorit kattavaa tutkimusaineistoa ei ole ollut saatavilla. Tulevien vuosien sosiaali- ja terveydenhuollon k

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1593::8fc411e03bc7c15402ac956dbeaabe23
http://hdl.handle.net/10138/168376

The Expiry of Humira ^® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures.

Autor: Moorkens E; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Godman B; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.; Division of Public Health Pharmacy and Management, School of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden., Huys I; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Hoxha I; Department of Pharmacy, University of Medicine Tirana, Tirana, Albania., Malaj A; Department of Pharmacy, University of Medicine Tirana, Tirana, Albania., Keuerleber S; Austrian Social Insurance, Vienna, Austria., Stockinger S; Austrian Social Insurance, Vienna, Austria., Mörtenhuber S; Austrian Social Insurance, Vienna, Austria., Dimitrova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Tachkov K; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Vončina L; Faculty of Health Studies, University of Rijeka, Rijeka, Croatia., Palčevski VV; Faculty of Health Studies, University of Rijeka, Rijeka, Croatia., Achniotou G; Health Insurance Organization (HIO), Nicosia, Cyprus., Slabý J; State Institute for Drug Control, Prague, Czechia., Popelková L; State Institute for Drug Control, Prague, Czechia., Kohoutová K; State Institute for Drug Control, Prague, Czechia., Bartels D; Amgros, Copenhagen, Denmark., Laius O; State Agency of Medicines, Tartu, Estonia., Martikainen JE; Pharmaceuticals Pricing Board, Ministry of Social Affairs and Health, Helsinki, Finland., Selke GW; AOK Research Institute (WIdO), Berlin, Germany., Kourafalos V; National Organization for the Provision of Healthcare Services (EOPYY), Athens, Greece., Magnússon E; Ministry of Welfare, Reykjavik, Iceland., Einarsdóttir R; The National University Hospital of Iceland, Reykjavik, Iceland., Adams R; St James's Hospital, Dublin, Ireland., Joppi R; Clinical Research and Drug Evaluation Unit, Local Health Authority of Verona, Verona, Italy., Allocati E; Mario Negri Institute for Pharmacological Research (IRCCS), Milan, Italy., Jakupi A; UBT - Higher Education Institute, Prishtina, Kosovo., Viksna A; Department of Medicines and Medical Devices, The National Health Service, Riga, Latvia., Greičiūtė-Kuprijanov I; Ministry of Health of the Republic of Lithuania, Vilnius, Lithuania., Vella Bonanno P; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom., Suttorp V; Erasmus University Medical Center, Rotterdam, Netherlands., Melien Ø; Reviews and Health Technology Assessments, Norwegian Institute of Public Health, Oslo, Norway., Plisko R; HTA Consulting, Cracow, Poland., Mardare I; Public Health and Management Department, Faculty of Medicine, 'Carol Davila', University of Medicine and Pharmacy Bucharest, Bucharest, Romania., Meshkov D; V. A. Trapeznikov Institute of Control Sciences of Russian Academy of Sciences, Moscow, Russia., Novakovic T; ZEM Solutions, Belgrade, Serbia., Fürst J; Health Insurance Institute, Ljubljana, Slovenia., Zara C; Drug Area, Catalan Health Service, Barcelona, Spain., Marković-Peković V; Department of Social Pharmacy and Pharmacy Practice, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina., Grubiša N; Health Insurance Fund, Banja Luka, Bosnia and Herzegovina., Befrits G; Stockholm County Council, Stockholm, Sweden., Puckett R; NHS Greater Glasgow and Clyde, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Vulto AG; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Erasmus University Medical Center, Rotterdam, Netherlands.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2021 Jan 08; Vol. 11, pp. 591134. Date of Electronic Publication: 2021 Jan 08 (Print Publication: 2020).

Children's Relative Age and ADHD Medication Use: A Finnish Population-Based Study.

Autor: Vuori M; Department of Teacher Education, Turku Institute of Advanced Studies, miika.vuori@utu.fi., Martikainen JE; Research Unit and., Koski-Pirilä A; Statistical Information Service, The Social Insurance Institution (Kela), Helsinki, Finland., Sourander A; Department of Child Psychiatry, and.; Department of Child Psychiatry, Turku University Hospital, Turku, Finland.; Invest Flagship, University of Turku, Turku, Finland., Puustjärvi A; Kuopio University Hospital, Kuopio, Finland; and., Aronen ET; Department of Child Psychiatry and.; Laboratory of Developmental Psychopathology, Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Chudal R; Department of Child Psychiatry, and.; Department of Child Psychiatry, Turku University Hospital, Turku, Finland., Saastamoinen LK; Research Unit and.

Publikováno v: Pediatrics [Pediatrics] 2020 Oct; Vol. 146 (4). Date of Electronic Publication: 2020 Sep 21.

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research.

Autor: Aarnio E; School of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland; Institute of Biomedicine, University of Turku, FI-20014 University of Turku, Finland. Electronic address: emma.aarnio@uef.fi., Huupponen R; Institute of Biomedicine, University of Turku, FI-20014 University of Turku, Finland. Electronic address: risto.huupponen@utu.fi., Martikainen JE; The Social Insurance Institution of Finland, P.O. Box 450, 00056, Kela, Finland. Electronic address: jaana.e.martikainen@gmail.com., Korhonen MJ; Institute of Biomedicine, University of Turku, FI-20014 University of Turku, Finland. Electronic address: maarit.korhonen@utu.fi.

Publikováno v: Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2020 Apr; Vol. 16 (4), pp. 553-559. Date of Electronic Publication: 2019 Jun 22.

Second-line pharmacotherapy intensification after metformin monotherapy in type 2 diabetes: a nationwide register study from Finland during 2011–2022.

Autor: Rättö, Hanna¹ (AUTHOR) hanna.ratto@kela.fi, Kurko, Terhi¹ (AUTHOR), Pajunen, Pia² (AUTHOR), Kastarinen, Helena³ (AUTHOR)

Publikováno v: BMC Health Services Research. 8/19/2024, Vol. 24 Issue 1, p1-7. 7p.